- Human（2）
No data
- His Tag（1）
- His Tag & Avi Tag（1）
No data
- HEK293（2）
No data
- Biotin-labeled（1）
- Unconjugated（1）
No data
- RUO（2）
No data
- No（2）
No data
- 100ug/$300.00
- 1mg (500ug X 2)/$1855.00
No data
- 25ug/$360.00
- 200ug/$1420.00
No data
| Molecule | Cat. No. | Product Name | 種 | Host | Structure | Purity | Activity | Size&Price |
|---|---|---|---|---|---|---|---|---|
| IFN-omega | Human IFN-omega Protein, His Tag (BLI & MALS verified) |  Human | HEK293 |  | MALSSDS-PAGE | $300.00 100ug | ||
| IFN-omega | Avitag IFA-H82E3 | Biotinylated Human IFN-omega Protein, His,Avitag™ (MALS & SPR verified) | Human | HEK293 |  | MALSSDS-PAGE | $360.00 25ug |
| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| Bexotegrast | PLN-74809 | Phase 3 Clinical | Pliant Therapeutics Inc | Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19); Respiratory Distress Syndrome, Adult; Cholangitis, Sclerosing | 詳細 |
| IDL-2965 | IDL-2965 | Phase 2 Clinical | Indalo Therapeutics Inc | Metabolic Dysfunction-Associated Steatotic Liver Disease; Idiopathic Pulmonary Fibrosis | 詳細 |
| Nesvategrast | OTT-166(OcuTerra Therapeutics); SF-0166 | Phase 2 Clinical | Scifluor Life Sciences Inc, OcuTerra Therapeutics Inc | Diabetic macular oedema; Diabetic Retinopathy; Macular Degeneration | 詳細 |
| 18F-αvβ6-Binding-Peptide | 18F-αvβ6-BP | Phase 1 Clinical | National Cancer Institute, National Institutes Of Health | Rectal Neoplasms; Pancreatic Neoplasms; Coronavirus Disease 2019 (COVID-19); Colonic Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Metastatic breast cancer | 詳細 |
| [18F]FP-R01-MG | [18F]FP-R01-MG; [18F]FP-R01-MG-F2 | Phase 1 Clinical | Pliant Therapeutics Inc, Stanford University, Chinese Academy Of Medical Science & Peking Union Medical College | Small Cell Lung Carcinoma; Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19); Pancreatic Neoplasms; Cholangitis, Sclerosing; Brain metastases; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung | 詳細 |
| Ga-68-Trivehexin | RAD-301 | Phase 1 Clinical | Trimt GmbH | Pancreatic Neoplasms; Carcinoma, Pancreatic Ductal | 詳細 |
